TrialThe Journal of allergy and clinical immunology2019

Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy.

Robert Heddle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.